Qualigen Therapeutics
QLGN
QLGN
23 hedge funds and large institutions have $3.58M invested in Qualigen Therapeutics in 2020 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
11% less capital invested
Capital invested by funds: $4.01M → $3.58M (-$428K)
54% less call options, than puts
Call options by funds: $507K | Put options by funds: $1.1M
Holders
23
Holding in Top 10
–
Calls
$507K
Puts
$1.1M
Top Buyers
| 1 | +$247K | |
| 2 | +$188K | |
| 3 | +$170K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$117K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
+$97K |
Top Sellers
| 1 | -$123K | |
| 2 | -$27K | |
| 3 | -$22.5K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$15.1K |
| 5 |
Morgan Stanley
New York
|
-$1.4K |